GlassScriptPhysician profile
Mary B Biddy
NPI 1770081788
$3,762.91
in general payments reported to CMS, 2019-2025
14 companies · $149 in 2025
The $149 reported for 2025 was more than what a typical Surgical provider received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $2,870 · 2022: $393 · 2023: $177 · 2024: $175 · 2025: $149.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $500.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $500.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $2,782.68 | 2021 | |
| Smith+Nephew, INC. | $420.26 | 2022-2025 | Collagenase Santyl, Acticoat 4" X 4", Allevyn Life L 15.4x15.4 Ctn10 |
| Abbvie INC. | $132.67 | 2023-2024 | |
| Gentleman Orthopedic Solutions | $86.99 | 2021 | |
| Advanced Oxygen Therapy INC. | $86.12 | 2025 | Topical Oxygen Chamber For Extremities |
| Coloplast Corp | $60.15 | 2024 | |
| Medline Industries LP | $41.92 | 2022 | |
| Urgo Medical North America, LLC | $41.50 | 2023-2024 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap |
| Kci USA, INC. | $29.24 | 2022-2023 | V.A.C. Veraflo |
| Triad Life Sciences INC. | $18.40 | 2022 | |
| Boston Scientific Corporation | $17.38 | 2025 | Patient Trial Kit |
| Solventum Corporation | $15.93 | 2024 | V.A.C. Veraflo Cleanse Choice |
| Hollister Incorporated | $15.92 | 2022 | |
| Integra Lifesciences Corporation | $13.75 | 2023 | Tcc-Ez |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mary Biddy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.